Webinars Archives - Page 5 of 16 - EMEA

This site provides INTERCEPT product information for International audiences .

Strategies to minimise budget impact and increase cost effectiveness of pathogen inactivation

Strategies to minimise budget impact and increase cost effectiveness of pathogen inactivation

by jaycornell | May 5, 2025

Filip De Groof Consultant Cerus BV

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

by jaycornell | May 5, 2025

Dr. Konrad Rosskopf Dept. Transfusion Medicine University Hospital of Graz, Austria

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

by jaycornell | May 5, 2025

Dr. Konrad Rosskopf Dept. Transfusion Medicine University Hospital of Graz, Austria

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

by jaycornell | May 5, 2025

Dr. Konrad Rosskopf Dept. Transfusion Medicine University Hospital of Graz, Austria

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

Pathogen reduction of double dose platelet concentrates from pools of eight Buffy coats: product quality, safety and economic aspects

by jaycornell | May 5, 2025

Dr. Konrad Rosskopf Dept. Transfusion Medicine University Hospital of Graz, Austria

« Older Entries

Next Entries »